Rhamnocitrin

Rhamnocitrin

SCHEMBL1759429

COc1cc(O)c2c(=O)c(O)c(-c3ccc(O)cc3)oc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 1.00
CYP3A4 P08684 5/20 0.81
KDM4E B2RXH2 4/20 0.81
IP6K2 Q9UHH9 4/20 0.81
MEN1 O00255 3/20 0.81
LMNA P02545 3/20 0.81
MAPT P10636 3/20 0.81
KMT2A Q03164 3/20 0.81
IPMK Q8NFU5 3/20 0.81
APP P05067 2/20 0.81
AKR1B1 P15121 2/20 0.81
HSD17B10 Q99714 2/20 0.81
TDP1 Q9NUW8 2/20 0.81
RECQL P46063 2/20 0.81
THRB P10828 1/20 0.81
ELAVL3 Q14576 1/20 0.81
CYP1A1 P04798 4/20 0.79
CYP1A2 P05177 4/20 0.79
CYP1B1 Q16678 4/20 0.79
ABCB1 P08183 4/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rhamnocitrin SCHEMBL29903288 1.00 MAOA (1.00) MAOACYP3A4KDM4EIP6K2MEN1
SCHEMBL748643 0.95 MAOA (0.90) MAOACYP3A4KDM4EIP6K2MEN1
Izalpinin SCHEMBL29974286 0.91 MAOA (0.83) MAOACYP3A4KDM4EIP6K2MEN1
Izalpinin SCHEMBL7551775 0.91 MAOA (0.83) MAOACYP3A4KDM4EIP6K2MEN1
Rhamnetin SCHEMBL7164573 0.90 MEN1 (1.00) MAOACYP3A4KDM4EIP6K2MEN1
Rhamnetin SCHEMBL29453025 0.90 MEN1 (1.00) MAOACYP3A4KDM4EIP6K2MEN1
Rhamnetin SCHEMBL29496169 0.90 MEN1 (1.00) MAOACYP3A4KDM4EIP6K2MEN1
Rhamnetin SCHEMBL555118 0.90 MEN1 (1.00) MAOACYP3A4KDM4EIP6K2MEN1
Kumatakenin SCHEMBL3351483 0.88 KDM4E (0.83) MAOACYP3A4KDM4EIP6K2MEN1
Kumatakenin SCHEMBL29681818 0.88 KDM4E (0.83) MAOACYP3A4KDM4EIP6K2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 416 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12419317-B1 Plant derived food preservative IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) 2025-09-23 US claimed
CN-120084909-A Multi-component content determination method for four-ingredient Tibetan cat-milk soup 青岛科技大学 2025-06-03 CN claimed
CN-119139368-A Application of West river Liu Xin 山东中医药大学 2024-12-17 CN claimed
CN-119007852-A Screening method of chemical component group with renal anemia treatment effect 深圳市中医院 2024-11-22 CN claimed
CN-118384285-A Nanometer medicine based on bifilar framework nucleic acid tetrahedron and preparation method and application thereof 海南医学院 2024-07-26 CN claimed
US-11896709-B2 Natural vegetable source based hair colour GODREJ CONSUMER PRODUCTS LTD. (IN) 2024-02-13 US claimed
WO-2023219526-A1 MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT PROKIN MILAN (RS) 2023-11-16 WO claimed
US-20230270662-A1 NATURAL VEGETABLE SOURCE BASED HAIR COLOUR GODREJ CONSUMER PRODUCTS LTD. (IN) 2023-08-31 US claimed
CN-113804775-B Construction method of patchouli fingerprint based on mass spectrometry technology and multi-index quantitative evaluation method 广东省科学院测试分析研究所(中国广州分析测试中心) 2023-05-12 CN claimed
CN-112512518-B Hydroxygenkwanin nanoparticles, preparation method thereof and application thereof in antitumor drugs 中国医学科学院药用植物研究所 2023-01-10 CN claimed
CN-1787834-A One or several enzyme-containing compounds, dietetic food products and drugs produced from said compounds and the use therefor for medical purposes MUCOS PHARMA GMBH & CO (DE) 2006-06-14 CN claimed
CN-1679696-A Medicine containing notoginseng, seabuckthorn fruit and flatstem milkvetch seed for cardio-cerebral blood vessel diseases and its preparation FUKANGREN BIO PHARMACEUTICAL S (CN) 2005-10-12 CN claimed
CN-1679702-A Medicinal preparation containing notoginseng and flatstem milkvetch seed for cardio-cerebral blood vessel diseases and its preparing method FUKANGREN BIO PHARMACEUTICAL S (CN) 2005-10-12 CN claimed
CN-1454093-A Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections CONTROL OX OY (FI) 2003-11-05 CN claimed
CN-1383381-A Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives KOREA INST ORIENTAL MEDICINE (KR) 2002-12-04 CN claimed
EP-0290442-A4 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. CHEMEX PHARMACEUTICALS INC (US) 1990-07-03 EP claimed
EP-0290442-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-11-17 EP claimed
US-4774229-A ANTITUMOR AGENTS, SKIN DISORDERS, CANCER TREATMENT CHEMEX PHARMACEUTICALS, INC. (US) 1988-09-27 US claimed
WO-1988003805-A1 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS CHEMEX PHARMACEUTICALS, INC. (US) 1988-06-02 WO claimed
WO-1987006833-A1 MODIFICATION OF PLANT EXTRACTS FROM ZYGOPHYLLACEAE CHEMEX PHARMACEUTICALS, INC. (US) 1987-11-19 WO claimed